You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(600196.SH):子公司杏脈科技佈局AI影像診斷,打造“AI+X”智慧醫療生態
格隆匯 02-14 17:43

格隆匯2月14日丨復星醫藥(600196.SH)在互動平臺表示,公司高度重視且密切關注人工智能(AI)技術在醫藥醫療領域的變革潛力,目前已開展多項應用和嘗試,包括(1)內部已上線基於全球領先基礎大模型自研的PharmAID決策智能體平臺,可覆蓋全員,致力於提升工作效率、降低成本。(2)研發方面,已與AI藥品研發企業英矽智能、深勢科技等達成合作,共同推進小分子創新藥的開發;積極推動研發團隊評估、使用內外部工具模型,探索在分子生成、毒理優化、翻譯、醫學寫作、情報分析、專利分析等方面的應用,以提升研發的速度及效率,並探索應用大模型提升研發決策與投資回報率。(3)營銷方面,應用人工智能技術開展銷售人員智能化培訓並逐步走向業務輔助,助力員工自主高效學習與能力提升。(4)產品應用方面,子公司杏脈科技佈局AI影像診斷,打造“AI+X”智慧醫療生態,在放射、病理、超聲方面的產品已經在臨牀上推廣應用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account